GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » EV-to-EBIT

Genenta Science SPA (Genenta Science SPA) EV-to-EBIT : -3.12 (As of May. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Genenta Science SPA's Enterprise Value is $39.75 Mil. Genenta Science SPA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-12.75 Mil. Therefore, Genenta Science SPA's EV-to-EBIT for today is -3.12.

The historical rank and industry rank for Genenta Science SPA's EV-to-EBIT or its related term are showing as below:

GNTA' s EV-to-EBIT Range Over the Past 10 Years
Min: -23.18   Med: 0   Max: 0
Current: -3.14

GNTA's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Biotechnology industry
Industry Median: 10.295 vs GNTA: -3.14

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Genenta Science SPA's Enterprise Value for the quarter that ended in Dec. 2023 was $69.70 Mil. Genenta Science SPA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-12.75 Mil. Genenta Science SPA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -18.29%.


Genenta Science SPA EV-to-EBIT Historical Data

The historical data trend for Genenta Science SPA's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA EV-to-EBIT Chart

Genenta Science SPA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - -25.52 -5.96 -5.08

Genenta Science SPA Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only -25.52 - -5.96 - -5.08

Competitive Comparison of Genenta Science SPA's EV-to-EBIT

For the Biotechnology subindustry, Genenta Science SPA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genenta Science SPA's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genenta Science SPA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Genenta Science SPA's EV-to-EBIT falls into.



Genenta Science SPA EV-to-EBIT Calculation

Genenta Science SPA's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=39.746/-12.746
=-3.12

Genenta Science SPA's current Enterprise Value is $39.75 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genenta Science SPA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-12.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genenta Science SPA  (NAS:GNTA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Genenta Science SPA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-12.746/69.69915
=-18.29 %

Genenta Science SPA's Enterprise Value for the quarter that ended in Dec. 2023 was $69.70 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genenta Science SPA's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-12.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genenta Science SPA EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Genenta Science SPA (Genenta Science SPA) Business Description

Traded in Other Exchanges
Address
Via Olgettina No. 58, Milan, ITA, 20132
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.